Orthobunyaviruses are enveloped viruses that can cause human and animal diseases. A novel and major member is the Schmallenberg virus (SBV), the etiological agent of an emerging disease of ruminants that has been spreading all over Europe since 2011. The glycoproteins Gn and Gc of orthobunyaviruses mediate the viral entry, and specifically Gc is a major target for the humoral immune response. For example, the N terminal subdomain of the SBV glycoprotein Gc is targeted by neutralizing monoclonal antibodies that recognize conformational epitopes. Here, we determined the structural features of the N terminus of Gc, and analysed its interaction with monoclonal antibodies. We were able to demonstrate that one of two N-glycosylation sites is essential for secretion and interaction with a subset of Gc-specific monoclonal antibodies. Furthermore, four disulfide bonds (S-S) were identified and the deletion of the third S-S blocked reactivity with another subset of mAbs with virus-neutralizing and non-neutralizing activity. The mutagenesis of the N-glycosylation sites and the disulfide bonds strongly indicated the independent folding of two subdomains within the SBV Gc N terminus. Further, the epitopes recognized by a panel of mAbs could be grouped into two clusters, as revealed by fine mapping using chimeric proteins. Combining the disulfide bonding and epitope mapping allowed us to generate a structural model of the SBV Gc Nterminus. This novel information about the role and structure of the amino terminal region of SBV Gc is of general relevance for the design of antivirals and vaccines against this virus.
INTRODUCTION
The viruses within the Bunyaviridae family include important human and animal pathogens [1] . The genus Orthobunyavirus includes, among other viruses, the recently discovered Schmallenberg virus (SBV) [2] , which affects ruminants and has spread tremendously in recent years. The genome of orthobunyaviruses comprises three singlestranded RNA segments of negative polarity, which according to their size are designated as small (S), medium (M) and large (L), respectively [3] . The S segment encodes the nucleocapsid protein N and the non-structural protein S (NSs), whereas the viral polymerase is synthesized from the L segment [3] . The M segment encodes a polypeptide [4, 5] that, upon processing by cellular peptidases, yields the mature envelope glycoproteins Gn and Gc, along with the non-structural protein NSm [6] . The Gn and Gc glycoproteins mediate viral entry and form heterodimers, very likely through their transmembrane regions [7, 8] , during budding in the Golgi complex. Interestingly, a peptide derived from the NSm protein was found to be required for viral fusion [6] .
Understanding the contribution of the Gc protein during the entry of orthobunyaviruses was the aim of a series of studies. The Gc protein of the California serogroup orthobunyavirus LaCrosse Virus (LACV) is a fusogenic protein that mediates membrane merging during the fusion process [9] [10] [11] and also facilitates e.g. attachment to the cell membrane [12] , and is targeted by virus neutralizing antibodies [13, 14] . However, neutralizing antibodies elicited by the glycoprotein ectodomains did not confer protection against the nairovirus Crimean-Congo hemorrhagic fever virus [15] . A domain at the N terminus of the Gc protein of LACV and the closely related snowshoe hare virus is recognized by polyclonal sera and also by monoclonal antibodies (mAbs) generated against virus particles [5, 13, 16, 17] . This domain can be removed by trypsin digestion and the virions retain their infectivity [13, 16, 17] .
We recently affinity-purified an N-terminal subdomain of the Gc protein of SBV, which we named the 'SBV Gc amino' [18] . This protein domain reacted with sera from convalescent animals, and interestingly with the majority of murine mAbs with a virus-neutralizing activity. These mAbs recognized conformational epitopes that were destroyed upon reduction of the disulfide bonds [18] . This subdomain is therefore a very attractive candidate for the development of vaccines and antivirals. Nevertheless, such approaches should be supported by structural information about this domain and identification of the molecular determinants of neutralization.
We generated therefore chimeric proteins from the 'SBV Gc amino', and showed that the available mAbs were directed against two different clusters. A glycosylation site was essential for protein secretion and folding of the epitopes located in one cluster, but dispensable for the others. We determined the four disulfide bonds of the domain by MS and showed that the deletion of each one affects the binding of different mAbs. In addition, the mutagenesis of the third disulfide bond in a full-length infectious SBV clone abolished the ability to replicate.
With the new insights acquired here, we have developed a two-dimensional model of the SBV Gc N-terminal domain, in which the residues that are relevant for neutralization are highlighted.
RESULTS

Expression and characterization of the SBV Gc N-terminal domain
We previously showed that the amino terminal domain of the SBV Gc (SBV Gc amino) could be expressed without the rest of the protein [18] . The fragment comprising residues Ile469 to Ile702 was flanked upstream by a mammalian signal peptide, and downstream by a Strep-affinity tag for expression in 293T cells (Fig. 1a) . This strategy allows the protein to be secreted by the cells, which does not occur when the full-length Gc is expressed.
The protein was purified to homogeneity and migrated at a size of~37 kDa in SDS-PAGE, which is in accordance with the predicted molecular weight of 30.35 kDa (Fig. 1b) plus the two N-glycosylation sites at positions 493 and 686, respectively. Both bands of the doublet were recognized by the anti-StrepTag antibody, which indicates that the faster migrating band is not a carboxyl-terminal truncated protein. The formation of intramolecular disulfide bonds is implied by the slight shift observed upon reduction.
In addition, a correct overall conformation of the protein can be assumed, as it reacts with sera from infected animals and also with (mAbs) directed against conformational epitopes [18] . To gain further direct information on the secondary structure and the folding of SBV Gc amino, we analysed the protein by circular dichroism spectroscopy. The estimation of the secondary structure using the method described by Raussens et al. [19] suggested a well-folded protein with 45 % alpha helices (including beta turns) and 17.4 % beta sheets (Fig. S1 , available in the online Supplementary Material). Therefore, the SBV Gc amino isolated from eukaryotic cells could be identified as an alpha-helixrich protein with intramolecular disulfide bonds.
The role of glycosylation on SBV Gc amino secretion and reaction with mAbs We first analysed whether the heterogeneity in the molecular weight observed for SBV Gc amino is due to the presence of glycans. To this end, the usage of the two potential glycosylation sites, named NGlyc-1 and NGlyc-2 ( Fig. 2a) , was determined by site-directed mutagenesis and enzymatic oligosaccharide removal with PNGase F.
When the proteins were treated with the enzyme, a single band corresponding to the calculated molecular weight was observed in cell lysates (Fig. 2b) and in the supernatant, in cases where the protein was still secreted (Fig. 2c) . When the first glycosylation site was mutagenized, the secretion of the protein was abolished, and three different bands were detected, one of them of the size of the fully deglycosylated protein. When the second predicted glycosylation site was modified, the protein was still secreted and two bands were observed, although not at the predicted size of the protein without glycans. Furthermore, the disruption of both sites (DNGlyc-1-2) led to a lack of secretion of the protein. In addition to the expected and more prominent band of the glycan-free protein, a fainter band of a higher molecular weight persisted in the sample lysate where both predicted glyosylation sites were knocked out, but this product was not observed in the secreted protein. The results demonstrated that both N-glycosylation sites are obviously used, and that the protein is glycosylated at an additional position.
Since the proteins DNGlyc-1 and DNGlyc-1-2 were not secreted, the reaction of the mAbs with these mutants was assessed by an indirect immunofluorescence test. The reactivity fell into two broad patterns: (i) those where the reactivity was preserved at wild-type levels, and (ii) those where the reactivity was completely lost. Representatives of each of these phenotypes are shown in Fig. 2d . Only the epitopes reactive with the mAbs 1C11, 1C1 and 3A5 were preserved, whereas the other mAbs no longer reacted with these mutants. The reaction of each of these mAb with the DNGlyc-2 mutant was also evaluated by ELISA using a purified protein preparation. All mAbs recognized this protein as efficiently as they did the wild-type (Fig. 2e) . The reaction of selected mAbs with the three N-glycosylation mutants is also shown in Fig. S5 .
Hence, the SBV Gc amino is most likely N-glycosylated at the two predicted sites, with the first being crucial for both protein secretion and interaction with five of the tested mAbs.
Determination of disulfide bonding of SBV Gc amino by MS
In the first approach, disulfide bonds were mapped by MALDI-TOF MS. The position of the cysteines is based on the published sequence of the SBV full-length glycoprotein [2] .
The MALDI-TOF MS analysis was carried out with tryptic peptides of gel-purified samples with and without treatment with reducing reagents. In this way, masses corresponding to tryptic peptides linked by the respective disulfide bonds were identified between cysteines 523 and 550 (3900.03 Da) (S-S#2), 580 and 589 (1942.95 Da) (S-S#3), and 591 and 598 (1375.53 and 1391.53 Da) (S-S#4) (Fig. S2) . None of the three masses were detectable in spectra from reduced samples, confirming that they represented disulfide-linked peptides. As no free cysteine residues were detected in the unreduced protein, MALDI-TOF MS analysis strongly suggested a disulfide pattern in which the remaining cysteine residues C471 and C487 were also linked (Fig. 3a) .
As the MALDI-TOF MS signal from the C523-C550 linked peptides was weak, and since there was no direct evidence for the linkage of C471 to C487, mass spectrometric analysis was repeated on a nanoHPLC-ESI-MS/MS platform. After parallel digestion of unreduced samples with trypsin and chymotrypsin, all four disulfide linkages could be confirmed by tandem MS (Fig. S2b) .
Analysis of the role of each disulfide bond on protein secretion and binding of SBV-Gc-specific mAbs We previously showed that the disulfide bonds are crucial for the folding of the epitopes recognized by all the tested mAbs on the SBV Gc amino, as reduction abolished their binding [18] . The effect of each disulfide bond on protein expression and secretion was assessed via Western blot analysis with mutagenized proteins (Fig. 3b, c) . The disruption of S-S#1, S-S#2 or S-S#4 led to the intracellular retention of the protein, and no protein could be recovered, even from either 250 or 500 ml volumes of supernatant (data not shown). Only the mutation of disulfide bond #3 (DS-S#3) allowed the protein to be secreted, although to a lesser extent when compared to the wild-type protein (Fig. 3c) . The absence of this disulfide bond was confirmed by MALDI-TOF MS analysis of the protein with the mutagenized S-S#3, where the 1942.95 Da mass was no longer observed due to the mutation of cysteines 580 and 589 to serine (Fig. S3) .
The resulting protein DS-S#3 could be isolated from the supernatant and its reaction with mAbs was tested in the respective ELISA. The mutagenized protein was recognized by the mAbs 2G10, 4D9, 4E5, 1F4 and 4B6, while the mAbs 1C11, 1C1 and 3A5 did not give any positive signal (Fig. 3d) . The secretion of the protein and its reaction with the other mAbs, as well as with the anti-StrepTag control antibody, indicate that the results are not attributable to degradation of the protein due to a reduction in its stability. Strep Tag mAb
Loading control Neg. Ctrol Furthermore, the reactivity of those mAbs with the mutated proteins DS-S#1, DS-S#2 or DS-S-4 was evaluated by indirect immunofluorescence using transfected cells (Figs. 3e and S6). This is a qualitative approach, but still valid to test the reactivity of these antibodies, as they recognize the respective epitopes under these conditions [20] .
The absence of S-S#1 or S-S#2 destroyed the epitopes of the mAbs 2G10, 4D9, 4E5, 1F4 and 4B6, whereas the mAbs 1C11, 1C1 and 3A5 still reacted with the mutated proteins (Fig. 3e ). In addition, the modification of S-S#4 produced a protein that did not give a clear reaction with any of the mAbs. The indirect immunofluorescence against the four proteins for most of the evaluated mAbs is shown in Fig. S6 .
In conclusion, the mutagenesis of disulfide bonds #1 and #2 affected protein secretion and the binding of five SBV-Gcspecific mAbs, whereas disulfide #3 still allowed protein secretion and was necessary for the interaction with three mAbs.
Influence of disulfide bond #3 on the virusneutralizing activity of a monospecific serum, reactivity with sera from convalescent animals and viral growth
The disruption of only disulfide bond S-S#3 allowed the protein to be secreted, suggesting a folding that was tolerated by the quality control of the cellular secretory pathway.
We wanted to assess the contribution of the relevant epitopes formed by this disulfide bond to virus neutralization. To this end, the virus-neutralizing activities of rabbit hyperimmune sera raised against the SBV Gc amino DS-S#3 or the SBV Gc amino wt protein were compared (Fig. 4a) . Even though both sera were able to neutralize SBV, the anti-SBV amino DS-S#3 serum showed a strikingly lower neutralizing titre. This difference in titre could not be attributed to a lower antibody titre against wild-type SBV, since an indirect ELISA with serial dilutions of both sera even indicated a slightly higher antibody level of the anti-mutant protein serum (Fig. 4b ).
Since the antibodies in sera from infected cattle are mainly generated against viral particles, we analysed the effect that the disruption of the S-S#3 would have on their reaction with this antigen (Fig. 4c) . The sera were evaluated in parallel with equal amounts of both proteins (Fig. 4c) . In this experimental setup, the mutation of the disulfide bond S-S#3 led to a marked reduction of the reactivity when compared to wild-type SBV.
Finally, the importance of S-S#3 for virus infectivity was tested using an SBV full-length infectious clone. No virus recovery could be observed when cells were incubated with supernatant from SBVDS-S#3-transfected cells (Fig. S4) .
Thus, the S-S#3 contributes to the formation of epitopes that are critical for the neutralizing activity of an SBV-Gcamino-specific hyperimmune serum, and also for the reactivity of sera from infected animals with the protein. In addition, it might be of relevance for virus viability.
Identification of residues critical for the binding of anti SBV Gc mAbs to SBV Gc amino and analysis of their role for the neutralization of SBV We have already shown that all of the different mAbs used in this study react with conformational epitopes [18] . Hence, we generated chimeras of SBV Gc amino in which substitutions from the Sathuperi or Douglas virus sequences were introduced (Fig. 5a ). These viruses are closely related to SBV, but they differ in their reaction pattern with the selected mAbs [20] . The reactions with these chimeras were -T477A  S496N-V500G  V499M-N502D-E503A  S509F-V510P  Q513K  I516V-S518G  N524D  S533A  L549M-L552T  M597L  R619L  wt  E482D  Q475K-S476P-T477A  S496N-V500G  V499M-N502D-E503A  S509F-V510P  Q513K  I516V-S518G  N524D  S533A  L549M-L552T  M597L  R619L  wt  E482D  Q475K-S476P-T477A  S496N-V500G  V499M-N502D-E503A  S509F-V510P  Q513K  I516V-S518G  N524D  S533A  L549M-L552T  M597L  R619L  wt  E482D  Q475K-S476P-T477A  S496N-V500G  V499M-N502D-E503A  S509F-V510P  Q513K  I516V-S518G  N524D  S533A  L549M-L552T  M597L  R619L  wt   mAb 1C11  mAb 1F4  mAb 2G10 mAb 3A5 mAb 4B6 mAb 4D9 mAb 4E5 [47] (accession numbers HE795103 and HE795091, respectively) were aligned. The residues highlighted in either green or yellow were introduced at the corresponding position of the SBV Gc amino. The effect of the corresponding amino acids on the binding of the mAbs was evaluated in an ELISA system with purified mutant proteins evaluated in an ELISA system with purified proteins, and the reaction differences were expressed in comparison to the wild-type protein (Fig. 5b) .
The double mutants L549M-L552T and S496N-V500G affected the binding of mAbs 2G10, 4D9, 4E5 and 4B6 in this ELISA. In addition, the reactivity of mAbs 4E5 and 4B6 was also reduced when the triple-mutant protein V499M-N502D-E503A was used, but to a lesser extent. Further, the binding of mAbs 1C11, 1C1 and 3A5 was clearly diminished by the mutations R619L and M597L, although the latter had a less pronounced effect on the 1C11 mAb binding. Interestingly, for mAb 1F4 no binding reduction could be observed.
The reactivity with the single mutants M6241I, T649S, G684S-A685T, E690K-T692S and I702V (Fig. 5a ) was also analysed by indirect immunofluorescence using transfected cells, and all the mutated proteins were reactive with these mAbs (data not shown).
It was evident that the disulfide bond S-S#3 is involved in the epitopes recognized by mAbs 1C11, 3A5 and 1C1 (Fig. 3d) , which react against Sathuperi virus, but not against Simbu virus [20] . Considering that the residues present in the putative loop of S-S#3 are conserved between Sathuperi virus and SBV, but are divergent in Simbu virus (Fig. 6a) , we analysed their contribution to the reaction with these antibodies. To this end, we constructed a chimeric protein in which the SBV residues on this loop (SS#3Loop_Mut) were substituted by the homologs of Simbu virus to test its reactivity with the mAbs in the respective ELISA. The different mutations significantly affected the binding of the mAbs 1C11, 3A5 and 1C1, but not the rest of the mAbs tested (Fig. 6b) . The reaction of sera from SBVinfected animals was also tested in the ELISA system with the mutants, and a slight but not significant reduction could be observed (Fig. 6c) .
Finally, we wanted to evaluate whether the neutralizing capability of a monospecific hyperimmune serum can be modified by three of the mutants. Due to the clear effect on the interaction with the mAbs 2G10, 4D9, 4E5 and 4B6, the double-mutants L549M-L552T and S496N-V500G were used to generate specific hyperimmune sera. In addition, the mutant S509F-V510P was also considered, even though no evident effect of these mutations on the binding of the mAbs was observed, since the clear difference in the properties of the exchanged residues might reveal a relevant epitope that is not reactive with the mAbs tested. While a serum generated against the double-mutation L549M-L552T did not show a reduced neutralizing activity, the sera generated against the S496N-V500G and S509F-V510P mutants showed a markedly reduced neutralizing titre when compared to serum from an animal immunized with the wild-type protein (Fig. 7a) . This result is not due to a generally reduced interaction of these sera with the wild-type protein, as they showed a strong reaction in the ELISA test, comparable to that of the serum from the wild-type-protein-immunized animal (Fig. 7b) .
The above-described differences in the neutralization titre of these hyperimmune sera prompted us to analyse the reactivity of different SBV-positive bovine sera against each of the mutants (Fig. 7c) . All of the sera used reacted with the mutants L549M-L552T and S496N-V500G, and the extent of the reactivity was very similar to that observed for the wild-type SBV protein. However, only the S509F-V510P mutant was less efficiently recognized.
Suggested SBV Gc amino model -structural features and determinants of neutralization
The results from the mutagenesis studies, along with the disulfide bonding, support a putative model of the molecule showing the epitopes of the mAbs in two clusters (Fig. 8) .
Cluster A includes the residues 496-450 and 549-552, displayed in blue spheres, and cluster B includes the amino acids of the disulfide 3 loop, and the arginine 619, highlighted in red.
The amino acids 509-510, shown in green, were identified to be part of an epitope that is important for neutralization and was not recognized by the mAbs studied. The residues labelled in black were not relevant for the binding of the mAbs when mutagenized.
DISCUSSION
We recently succeeded in expressing and purifying an amino terminal subdomain from the SBV Gc protein (SBV GC amino), and showed that it reacts with mAbs that neutralized virus infection in vitro [18] . In the present study, we determined the structural features of this domain that are involved in forming the epitopes recognized by both neutralizing and non-neutralizing mAbs. Based on the results from the analysis of the disulfide bonding, together with the residues identified to be part of conformational epitopes, a model of the SBV Gc N-terminal region was generated.
The role of N-glycosylation of SBV Gc amino in the folding of epitopes N-linked glycosylation is often required for the correct folding of glycoproteins in the endoplasmic reticulum (for a review see [21] ). The protein lacking an N-linked glycosylation at the first site (DNGlyc-1) remained cell-associated, as has been observed with other glycoproteins [22] , and was not reactive with certain mAbs. Very likely, the oligosaccharides support the folding of the protein by facilitating the formation of disulfide bonds. Indeed, alteration of the VSV G protein N-glycosylation pattern in the vesicular stomatitis virus protein G led to protein aggregation linked to the presence of aberrant disulfide bonds and resulted in ER retention of the protein and lack of trimerization [23, 24] . Hence, it seems that the proper formation of the disulfide bonds in close proximity to the first N-glycosylation site is required for the epitopes recognized by certain anti-SBV Gc mAbs. Considering that all these antibodies reacted with disulfide-bond-dependent conformational epitopes, we suggest that certain disulfide bonds are built independent or dependent on glycosylation of the protein.
The disulfide bonding of SBV Gc amino and its relevance for antigenic structure and virus viability The involvement of disulfide bonds in the structure of conformational epitopes within envelope glycoproteins has been reported for different viruses before [25, 26] .
Here we showed that the disulfide bonding pattern of the SBV Gc N terminus most likely builds four loops (see Fig. 8 ). Furthermore, we determined that with the exception of disulfide bond S-S#3, the deletion of any of the other disulfide bonds abrogated the secretion of the protein. As already observed for human IL-24 [27] or Epstein-Barr virus gH [28] , this is very likely associated with a misfolding of the protein, its aggregation and final retention in intracellular membranes.
The anti-SBV mAbs used in the present study were generated against viral particles, and their reactivity is affected by reduction, hence they are very useful tools to test the correct folding mediated by the disulfide bonds within the Gc.
An overall correct folding of the SBV amino DS-S#3 protein is indicated by its secretion, its reactivity with several mAbs and the lack of evidence for new or aberrant disulfide bonds due to disulfide reshuffling when the protein was analysed by MS. However, the DS-S#3 monospecific hyperimmune serum revealed reduced neutralizing activity. In addition, the mutated protein was less reactive with sera from infected animals. Thus it appears that the epitopes formed by S-S#3 contribute significantly to efficient virus neutralization, even though the epitopes of other neutralizing mAbs are still present.
Mutation of the disulfide bond S-S#3 appears to result in a lethal or severely growth-inhibited phenotype for the virus, as indicated by our inability to rescue this virus mutant. This is not attributable to a change in the protein folding that affected the whole molecule, since the Gc protein of the mutant virus remained reactive with other mAbs. Such a clear effect was not expected, as orthobunyaviruses have shown a high plasticity of this domain. For example, a temperature-sensitive mutant of the Maguari virus was still infectious with a truncated Gc lacking this subdomain [29] , and the Bunyamwera virus tolerated insertion of a green fluorescent protein in this region [30] . Nevertheless, these mutants did not infect cells as efficiently as the wild-type virus. However, these results should always be interpreted while considering the limited efficiency of the SBV rescue system. So, the presence of a mutated replicating virus cannot be completely excluded because of the low efficiency of the virus rescue by reverse genetics. Although interesting, this result should be considered as preliminary, and it does not represent the main goal of this study.
Important residues of the SBV Gc amino domains involved in virus neutralization
A subdomain in the Gc proteins of orthobunyaviruses homologous to the SBV Gc amino used in this study was previously defined, and also reacted with neutralizing antibodies [5] (16). For example, the topological mapping of neutralizing mAb epitopes of LaCrosse virus G1 [31] and G2 [32] , Aino virus [33] and the hantaviral glycoproteins was reported [34] . However, to the best of our knowledge, this is the first study to address the fine mapping of critical residues in the Gc of an orthobunyavirus that are important for neutralization.
The SBV mAbs that we examined clearly formed two clusters, one of which was around the disulfide bond S-S#3 (see Fig. 8 ). The double mutations L549M-L552T and, to a lesser extent, S496N-V500G affected the binding of the same Fig. 7 . Evaluation of the influence of mutations in the SBV Gc amino on the virus-neutralizing activity of the monospecific hyperimmune sera generated, and their reactivity with sera from SBV-infected cattle. (a) Rabbits (one per protein) were immunized with either the wild-type protein (1) or the mutants S496N-V55G (2), S509F-V510P (3) and L549M-L552T (4). The sera were tested in a virus-neutralization test, and the titres are expressed as the reciprocal of the highest test dilution for which the virus infectivity was reduced by 50 %. (b) Reactivity of monospecific hyperimmune sera with the wild-type SBV Gc amino. A serial dilution of each serum was tested in an ELISA (see rabbit ELISA in the Methods section) with a hexahistidine-tagged SBV Gc amino. The serum against the wild-type protein was the same as in Fig. 4 . The results are representative for three independent ELISA experiments with the same serum. OD, optical density; K=1000. (b) Influence of mutations in SBV Gc amino on its reactivity with sera from SBV-infected cattle. The sera were tested in an ELISA system (see cattle ELISA in the Methods section), and the OD index values were calculated, with the median values marked by the line in each box. The boxes represent the 25th-75th percentiles and whiskers indicate interquartile ranges. Black dots represent outliers. The statistically significant differences between the value of the corresponding mutant and the wild-type protein are indicated with asterisks. The data for this analysis were derived from three independent ELISA experiments.
group of mAbs. Considering that these residues are very distant in the protein sequence, this reactivity pattern is characteristic for a conformational epitope. The binding of the mAbs to the mutants N561K, I611M-P617A, M624I, T649S, G684S-A685T and I702V (see Fig. 6a ) was analysed by indirect immunofluorescence and there were no obvious differences as compared to the wild-type protein (data not shown).
Interestingly, the virus-neutralizing capability of a serum specific for the L549M-L552T mutant (see Fig. 8 , cluster A) was diminished; however a serum generated against the S496N-V500G mutant (see Fig. 8 , cluster A) still showed neutralization at a level comparable to that of the wild-type.
In conclusion, the residues around L549-L552 seem to be more relevant than those surrounding S496-V500 for the binding of the mAbs as well as for virus neutralization. The folding mediated by disulfide bond S-S#3 was critical for the binding of mAbs, sera from convalescent animals and also for the virus neutralization of a hyperimmune serum. Furthermore, residues within the putative loop formed by the cysteines of S-S#3 (N581, T582, N583, P584, H585 and H587) as well as R619 were identified as being important for the binding. Therefore, S-S#3 seems to be essential to bring the residues to the native conformation present in the virions.
In each group, there is a mAb that does not neutralize virus infection in vitro despite binding to the same protein subdomain. However, one possible explanation might be differences in the direct antibody contact area, as has been suggested for some anti-hepatitis C virus mAbs [35] . Thus, we cannot exclude the possibility that the epitopes of the neutralizing antibodies might include additional residues not identified in this study.
A surprising result was the reduced virus neutralizing titre of the hyperimmune serum generated against the protein with the mutations S509F-V510P. This approach identified residues that were not part of the epitopes of the analysed mAbs. Even though the serum is from a single animal, the results appear to be reliable, as this serum reacted with the SBV Gc amino as strongly as the serum generated against the wild-type protein in the Gc-ELISA, indicating a comparable total antibody reactivity. A recent study using patient sera showed that the neutralizing humoral immune response against Dengue virus is focused on two amino acids at the surface of the Dengue virus E protein [36] . A similar approach might be amenable for identifying residues of the orthobunyaviral glycoproteins that are determinants for serotype specificity, which cannot be identified if the experiments rely exclusively on mAbs. The novel structural information provided by this study could be very useful in developing vaccines and antivirals against SBV. So, if the SBV Gc amino mutants that did not react with specific mAbs confer good protection in in vivo studies, differentiating infected from vaccinated animals (DIVA) vaccines based on this domain could be developed.
METHODS
Deglycosylation experiment HEK-293T cells were split into six-well plates and transfected after 24 h with 2.5 µg of DNA per well using branched polyethylenimine (PEI; Sigma-Aldrich). At 24 h after transfection the cells and supernatants were collected, and an aliquot was treated with PNGase F (New England Biolabs) according to the manufacturer's instructions. Briefly, aliquots of lysates and supernatants were treated with denaturation buffer at 100 C for 10 min. Subsequently, G7 reaction buffer, NP40 and 500 units of PNGase F were added to samples, and the reaction was incubated at 37
C for 1 h. Then the samples were analysed by SDS-PAGE under reducing conditions and the Strep-tagged proteins were detected using an HRP-conjugated anti-StrepTag mAb (StrepMABclassic HRPO; IBA).
SDS-PAGE and Western blot analyses
The proteins were separated under reducing or non-reducing conditions by SDS-PAGE [37] with 12 % acrylamide or 4-12 % gradient gels (Expedeon). Proteins were blotted onto the nitrocellulose membrane and the Western blotting was performed as previously described [38] . Actin served as a loading control and was visualized with an anti-beta-actinspecific mAbs (Sigma).
Cells and viruses
All cell lines were obtained from the Collection of Cell Lines in Veterinary Medicine (CCLV) at the Friedrich-LoefflerInstitut, Greifswald-Insel Riems, Germany, namely baby hamster kidney cells (BHK-21, clone BRS5, L194 CCLV), human embryonic kidney cells (HEK-293T, L1018 CCLV) and a BHK-21 cell line stably expressing the T7 RNA polymerase BSRT-7/5 (RIE583, CCLV) [39] . The SBV strain BH 80/11-04 [2] was provided by the virus collection of the Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Cattle sera Sera from cattle experimentally infected with culture-grown or cattle-passaged SBV (n=10) [40, 41] , as well as negative bovine sera (n=5), obtained from the SBV reference laboratory of the Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany, were also analysed. One positive and one negative bovine reference serum served as controls [41] . The status of the sera was controlled by serum neutralization assay and a commercially available ELISA system (IDEXX Schmallenberg Ab; IDEXX).
Murine mAbs
Eight previously characterized SBV-neutralizing (4D9, 4E5, 1C11, 1F4, 4B6, 1C1) and non-neutralizing (3A5, 2G10) mAbs were used in the analyses [20] .
Protein expression and purification
The SBV Gc amino domain and its mutants with a carboxyl-terminal twin-StrepTag were expressed and purified from transiently transfected HEK-293T cells as previously described [18] . The protein concentration was determined with Quick Start Bradford 1x dye reagent (Bio-Rad). The protein aliquots were stored at À80 C until use. Hexahistidine-tagged SBV Gc amino was also expressed in transiently transfected HEK-293T cells and was purified via immobilized metal affinity chromatography with a 1 ml Ni-NTA superflow cartridge (Qiagen), followed by high-performance liquid chromatography on a Superdex G-200 size exclusion column (GE Healthcare) using an ÄKTA FPLC unit (GE Healthcare). The protein concentration was determined as described above and the protein was aliquoted and stored at À80 C until use.
Circular dichroism (CD) spectroscopy CD spectra were recorded on a Jasco Instrument using 10 µM of freshly purified protein in 10 µM potassium phosphate buffer pH 7.4 at 25 C. The spectra recorded represent the average of five individual scans with the spectra of the buffer only subtracted. Secondary structure content was estimated using the method described by Raussens et al. [19] .
Generation of polyclonal sera in rabbits Polyclonal sera were generated in 10-week-old New Zealand white rabbits of 2 kg body weight (Charles River). The animals were primed with 50 µg protein and boosted at 1 and 2 weeks post-priming, respectively. Blood samples were taken before priming and after the last boost. The experiments were approved by the responsible ethics committee of the German Federal State of Mecklenburg-Western Pomerania (LALLF 7221.3-2.5-004/10). The presence of antibodies in the serum was controlled using an indirect ELISA, as described below.
Serum neutralization assay
The test was performed as previously described [41] . Briefly, the sera were heat-inactivated and tested in two-fold dilutions using 1/5 as the starting dilution; all samples were tested in quadruplicate. The presence of infectious virus was determined in BHK-21 (L164 CCLV) cells by the presence of a cytopathic effect after 3 days, and the neutralizing titre was expressed as ND50.
ELISA
Indirect ELISA using mAbs (referred to as mAb ELISA) was performed as follows. The procedure was carried out essentially as previously described [18] . Briefly, the ELISA plate (Maxisorb, Nunc) was incubated overnight with the corresponding antigen being diluted in carbonate buffer (Sigma) C, followed by a blocking step at room temperature with PBS-Tween 20 (0.05 %), 0.2 % IgG-free BSA (Roth). The murine antibodies were detected with an HRPO-conjugate anti-mouse IgG (Sigma) and upon incubation with substrate the OD was measured at 450 nm. An anti-Strep tag mAb (StrepMAB-classic, IBA Biotech) served as a positive control and was used to calculate the index values (mean sample OD-Mean negative control OD/mean positive control OD-mean negative control OD).
Indirect ELISA of bovine sera (referred to as cattle ELISA) was performed as follows. The bovine sera were diluted 1 : 10 in PBS-Tween 20 (0.05 %) and tested on medium binding plates (Microlon, Greiner) coated as mentioned above. The plate was blocked with PBS-Tween 20 (0.05 %) and the bovine antibodies were detected with an HRPOprotein G conjugate diluted in conjugate buffer [PBS-tween (0.05 %), 2 % fish skin gelatin (Sigma), 3 % IgG-free BSA (Roth)]. The anti-StrepTag mAb was also used as a positive control and was detected as described above.
Indirect ELISA of rabbit sera (referred to as rabbit ELISA) was performed as follows. The sera collected before and after the immunization were tested in duplicate using twofold dilutions from 1 : 1000 to 1 : 128 000 in PBS-Tween 20 (0.05 %). The assay was performed as described above for the bovine sera (cattle ELISA) using an HRPO-conjugated anti-rabbit IgG (Sigma). In this case the raw OD values were compared.
Indirect immunofluorescence
The reactivity of the mAbs with the respective protein expressed in transiently transfected HEK-293T cells was assessed by indirect immunofluorescence as previously described [18] .
Determination of disulfide bonds by MS
Peptide mass fingerprint MALDI-TOF mass spectra were recorded from gel-purified [37] samples after in-gel digestion with trypsin following standard procedures [42] . To detect disulfide-bridged peptides, the digest was carried out in parallel with or without reduction and the spectra were compared using Bruker's flexAnalysis (version 3.4) and SequenceEditor (version 3.2) software to calculate the expected masses. Spectra were registered on an UltrafleXtreme instrument (Bruker) operated under fleXControl software (version 3.4). Digests were prepared for MS using an HCCA matrix as suggested by the manufacturer (Bruker), and spotted onto an AnchorChip target with 800 mm diameter. Spectra were registered between 700 and 5000 m/z in the positive reflector mode.
The disulfide bridge analysis was performed by Proteome Factory (Proteome Factory, Berlin). In short, the protein was digested in-solution in parallel with trypsin and chymotrypsin. The acidified peptides were analysed by nanoHPLC-ESI-MS/MS. The LCMS system consisted of an Agilent 1100 nanoHPLC system (Agilent), a PicoTip electrospray emitter (New Objective) and an Orbitrap XL mass spectrometer (Thermo Fisher Scientific). Peptides were trapped and desalted on enrichment column (ZorbaÂ300 SB-C18, 0.3Â5 mm, Agilent) for 5 min (solvent: 2.5 % acetonitrile/0.5 % formic acid) and then separated on a Zorbax 300 SB-C18, 75 µm Â150 mm column (Agilent) using a linear gradient from 10 to 32 % B (solvent A: 5 % acetonitrile in water, solvent B: acetonitrile, both with 0.1 % formic acid). Ions of interest were data-dependently subjected to MS/MS according to the expected charge state distribution of the peptide ions. Extracted MS/MS data were analysed and the disulfide-bridged peptides were determined using Stavro X software (version 3.6.0) [43] .
Statistical analysis
For statistical analysis and graphical presentation, the R [version 3.2.4 (revised 16 March 2016, r70336)] software environment for statistical computing and graphics was used. The 'ggplot2' package was applied for the visualization of the results. To perform multiple comparisons of ELISA index values a post hoc test [least significant difference, LSD)] on ANOVA results was performed, applying the R package 'agricolae'. Differences representing P 0.05 were considered to be statistically significant. Multiple comparisons by LSD test were performed with Holm corrections.
Generation and analysis of mutagenized SBV full-length clone
The position of the residues is given according to the reported sequence of the glycoprotein encoded by the M segment of SBV (strain HE649913) [2] . The construction of rescue plasmids was performed as follows. Recombinant SBV was recovered using the protocol for the three-plasmid rescue system reported for Bunyamwera [44] essentially as previously described [45] . To this end, the plasmids pT7ri-bo_SBV_S, pT7ribo_SBV_M and pT7ribo_SBV_L containing the S, M and L fragments, respectively, were used [45] . For construction of pT7ribo_SBV_M_Mut-C two point mutations (G fi C at nucleotide positions 1739 and 1789) were introduced in two cloning steps into pT7ribo_SBV_M by fusion PCR [46] , resulting in substitution of the cysteines 580 and 589 to serine.
Expression plasmids
The construction of plasmids was performed as follows. The position of the residues is given according to the reported sequence of the glycoprotein encoded by the M segment of SBV (HE649913) [2] , Douglas virus (HE795091), Sathuperi virus (HE795103) and Simbu virus (HE795109), respectively [47] . A list of the plasmids is provided in Table S1 of the supplementary material.
Plasmids with chimeric SBV Gc amino were generated as follows. For the mutated constructs, the plasmid pGRS-12 or pGRS-12.1 as indicated (described in [18] ) served as the template and the site-directed mutagenesis was carried out using either Pfu DNA polymerase (Thermo Scientific) or Phusion HF (New England Biolabs) following standard molecular biology procedures. The four disulfide bonds were mutagenized individually (plasmids DS-S#1, 2, 3 and 4) and the two N-glycosylation sites were modified individually and in combination (plasmids DNGlyc-1,-2 and -1-2). A total of 19 plasmids were generated by exchanging residues in the plasmid pGRS-12 with those from Sathuperi virus (14 plasmids), Douglas virus (4 plamids), or Simbu virus (1 plasmid).
The plasmid expressing the hexahistidine-tagged SBV Gc amino domain (pGRS-58) was constructed using the plasmid pGRS-105_Ulm as the vector (Roman-Sosa, un published; kindly provided by Reinhold Schirmbeck, Universit€ atsklinikum Ulm).
Detailed information concerning the cloning strategies and oligonucleotide sequences (Table S2) is provided in the supplementary material. 
